Publication: SEOM clinical guidelines on cardiovascular toxicity (2018).
Loading...
Identifiers
Date
2019-01-09
Authors
Virizuela, J A
García, A M
de Las Peñas, R
Santaballa, A
Andrés, R
Beato, C
de la Cruz, S
Gavilá, J
González-Santiago, S
Fernández, T L
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Export
Abstract
One of the most common side effects of cancer treatment is cardiovascular disease, which substantially impacts long-term survivor's prognosis. Cardiotoxicity can be related with either a direct side effect of antitumor therapies or an accelerated development of cardiovascular diseases in the presence of preexisting risk factors. Even though it is widely recognized as an alarming clinical problem, scientific evidence is scarce in the management of these complications in cancer patients. Consequently, current recommendations are based on expert consensus. This Guideline represents SEOM's ongoing commitment to progressing and improving supportive care for cancer patients.
Description
MeSH Terms
Antineoplastic Agents
Cardiotonic Agents
Cardiotoxicity
Cardiovascular Diseases
Clinical Trials as Topic
Disease Management
Humans
Neoplasms
Practice Guidelines as Topic
Prognosis
Societies, Medical
Cardiotonic Agents
Cardiotoxicity
Cardiovascular Diseases
Clinical Trials as Topic
Disease Management
Humans
Neoplasms
Practice Guidelines as Topic
Prognosis
Societies, Medical
DeCS Terms
CIE Terms
Keywords
Cancer, Cardiotoxicity, Chemotherapy, Early detection, Risk assessment